-
1.发明申请NOVEL 1,2,3,4-TETRAHYDRO-PYRIMIDO(1,2-A)PYRIMIDIN-6-ONE DERIVATIVES, PREPARATION THEREOF, AND PHARMACEUTICAL USE THEREOF 有权新的1,2,3,4-四氢吡喃糖（1,2-A）嘧啶-6-酮衍生物，其制备方法及其药物用途公开(公告)号：US20120208810A1
公开(公告)日：2012-08-16
申请号：US13381790
申请日：2010-07-01
Applicant: Eric Bacque , Maurice Brollo , Annie Clauss , Youssef El Ahmad , Bruno Filoche-Romme , Frank Halley , Karl Andreas Karlsson , Gilbert Marciniak , Baptiste Ronan , Laurent Schio , Bertrand Vivet , Fabrice Viviani , Andre Zimmermann
Inventor： Eric Bacque , Maurice Brollo , Annie Clauss , Youssef El Ahmad , Bruno Filoche-Romme , Frank Halley , Karl Andreas Karlsson , Gilbert Marciniak , Baptiste Ronan , Laurent Schio , Bertrand Vivet , Fabrice Viviani , Andre Zimmermann
IPC: A61K31/5377 , A61P35/00 , A61P33/02 , A61P3/00 , A61P33/00 , A61P33/06 , C07D487/04 , A61P35/04
CPC classification number: C07D487/04 , A61K31/519 , A61K31/5377 , C07D239/06 , C07D239/42 , C07D413/14
Abstract: The invention relates to the novel materials of formula (I), where: R1 is an optionally substituted L-aryl or L-heteroaryl, such that L is a single bond, alkyl, CO, or CO-alk, or L-X, with L□ being an alkyl and X being O or S; R2 is H or alkyl; R3 is an alkyl optionally substituted by Hal; and R4 is Hou Hal, wherein said materials are in any isomeric form and the salts thereof, to be used as drugs.
Abstract translation: 本发明涉及式（I）的新型材料，其中：R1是任选取代的L-芳基或L-杂芳基，使得L是单键，烷基，CO或CO-或LX，与L □为烷基，X为O或S; R2是H或烷基; R3是任选被Hal取代的烷基; 并且R4是Hou Hal，其中所述材料是任何异构形式及其盐，用作药物。
-
2.发明授权Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof 有权喹唑啉二酮衍生物，其制备及其治疗用途公开(公告)号：US08242126B2
公开(公告)日：2012-08-14
申请号：US12754163
申请日：2010-04-05
Applicant: Annie Clauss , Christophe Glaess , Gilbert Marciniak , Nicolas Muzet , Jean-Francois Nave , André Seyer , Bertrand Vivet
Inventor： Annie Clauss , Christophe Glaess , Gilbert Marciniak , Nicolas Muzet , Jean-Francois Nave , André Seyer , Bertrand Vivet
IPC: A61K31/517
CPC classification number: C07D401/04 , C07D403/04 , C07D471/08
Abstract: The invention relates to quinazolinedione derivatives of the general formula (I): wherein A, R1, R2, R3, R4, m, n, p, p′, and r are as defined herein, processes for the preparation thereof and their therapeutic applications.
Abstract translation: 本发明涉及通式（I）的喹唑啉二酮衍生物：其中A，R1，R2，R3，R4，m，n，p，p'和r如本文所定义，其制备方法及其治疗应用 。
-
3.发明申请QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF 有权喹诺酮衍生物，其制备方法及其治疗用途公开(公告)号：US20100298298A1
公开(公告)日：2010-11-25
申请号：US12754163
申请日：2010-04-05
Applicant: Annie CLAUSS , Christophe GLAESS , Gilbert MARCINIAK , Nicolas MUZET , Jean-Francois NAVE , André SEYER , Bertrand VIVET
Inventor： Annie CLAUSS , Christophe GLAESS , Gilbert MARCINIAK , Nicolas MUZET , Jean-Francois NAVE , André SEYER , Bertrand VIVET
IPC: A61K31/55 , C07D403/04 , A61K31/517 , A61P25/02 , A61P19/02 , A61P3/10 , A61P35/00 , A61P3/14 , A61P11/06 , A61P1/00
CPC classification number: C07D401/04 , C07D403/04 , C07D471/08
Abstract: The invention relates to quinazolinedione derivatives, processes for the preparation thereof and their therapeutic applications.
Abstract translation: 本发明涉及喹唑啉二酮衍生物，其制备方法及其治疗应用。
-
Patent Agency Ranking
4.发明授权1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof 有权1,2,3,4-四氢 - 嘧啶并（1,2-a）嘧啶-6-酮衍生物及其药物用途公开(公告)号：US08846670B2
公开(公告)日：2014-09-30
申请号：US13381790
申请日：2010-07-01
Applicant: Eric Bacque , Maurice Brollo , Annie Clauss , Youssef El Ahmad , Bruno Filoche-Romme , Frank Halley , Karl Andreas Karlsson , Gilbert Marciniak , Baptiste Ronan , Laurent Schio , Bertrand Vivet , Fabrice Viviani , Andre Zimmermann
Inventor： Eric Bacque , Maurice Brollo , Annie Clauss , Youssef El Ahmad , Bruno Filoche-Romme , Frank Halley , Karl Andreas Karlsson , Gilbert Marciniak , Baptiste Ronan , Laurent Schio , Bertrand Vivet , Fabrice Viviani , Andre Zimmermann
IPC: A61K31/5377 , A61K31/519 , C07D413/14 , C07D487/04 , C07D239/06 , C07D239/42
CPC classification number: C07D487/04 , A61K31/519 , A61K31/5377 , C07D239/06 , C07D239/42 , C07D413/14
Abstract: The invention relates to compounds of the formula: or their racemic, enantiomeric or diastereoisomeric isomers, or pharmaceutically acceptable salts of the compounds of formula I or the racemic, enantiomeric or diasteroisomeric isomers.
Abstract translation: 本发明涉及下式的化合物或其外消旋，对映异构体或非对映异构体异构体或式I化合物的药学上可接受的盐或外消旋，对映异构体或非对映体异构体。
-
5.发明授权2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof 有权2,3-二氢-1H-咪唑并（1,2-a）嘧啶-5-酮衍生物及其药物用途公开(公告)号：US08828997B2
公开(公告)日：2014-09-09
申请号：US13381571
申请日：2010-07-01
Applicant: Maurice Brollo , Annie Clauss , Youssef El Ahmad , Bruno Filoche-Romme , Frank Halley , Karl Andreas Karlsson , Gilbert Marciniak , Baptiste Ronan , Laurent Schio , Bertrand Vivet , Fabrice Viviani , Andre Zimmermann
Inventor： Maurice Brollo , Annie Clauss , Youssef El Ahmad , Bruno Filoche-Romme , Frank Halley , Karl Andreas Karlsson , Gilbert Marciniak , Baptiste Ronan , Laurent Schio , Bertrand Vivet , Fabrice Viviani , Andre Zimmermann
IPC: A61K31/5377 , A61K31/519 , C07D413/14 , C07D487/04
CPC classification number: C07D487/04 , A61K31/519 , A61K31/5377 , C07D413/14 , Y02A50/409 , Y02A50/411 , Y02A50/414 , Y02A50/415
Abstract: The invention relates to a product of formula (I) where R1, R2, R3, and R4 are as defined herein, the therapeutic use of the product, a process to make the product, and a pharmaceutical composition comprising the product.
Abstract translation: 本发明涉及式（I）的产物，其中R 1，R 2，R 3和R 4如本文所定义，产物的治疗用途，制备该产品的方法以及包含该产品的药物组合物。
-
6.发明申请NOVEL 2,3-DIHYDRO-1H-IMIDAZO(1,2-A)PYRIMIDIN-5-ONE DERIVATIVES, PREPARATION THEREOF, AND PHARMACEUTICAL USE THEREOF 有权新的2,3-二氢-1H-咪唑并（1,2-A）嘧啶-5-酮衍生物，其制备方法及其药物用途公开(公告)号：US20120142679A1
公开(公告)日：2012-06-07
申请号：US13381571
申请日：2010-07-01
Applicant: Maurice Brolio , Annie Clauss , Youssef El Ahmad , Bruno Filoche-Romme , Frank Halley , Karl Andreas Karlsson , Gilbert Marciniak , Baptiste Ronan , Laurent Schio , Bertrand Vivet , Fabrice Viviani , Andre Zimmermann
Inventor： Maurice Brolio , Annie Clauss , Youssef El Ahmad , Bruno Filoche-Romme , Frank Halley , Karl Andreas Karlsson , Gilbert Marciniak , Baptiste Ronan , Laurent Schio , Bertrand Vivet , Fabrice Viviani , Andre Zimmermann
IPC: A61K31/5377 , A61P35/00 , A61P33/06 , A61P43/00 , A61P33/00 , A61P33/02 , C07D487/04 , A61P35/04
CPC classification number: C07D487/04 , A61K31/519 , A61K31/5377 , C07D413/14 , Y02A50/409 , Y02A50/411 , Y02A50/414 , Y02A50/415
Abstract: The invention relates to the novel materials of formula (I), where R1 is an optionally substituted L-aryl or -heteroaryl, such that L is: an alkyl or CO, or LX, with Lbeing an alkyl and X being O or S; R2 is H or an alkyl; R3 is an alkyl optionally substituted by Hal; and R4 is Hou Hal, wherein said materials are in any isomeric form and the salts thereof, to be used as drugs.
Abstract translation: 本发明涉及式（I）的新型材料，其中R 1是任选取代的L-芳基或杂芳基，使得L是：烷基或CO或LX，其中烷基和X是O或S; R2是H或烷基; R3是任选被Hal取代的烷基; 并且R4是Hou Hal，其中所述材料是任何异构形式及其盐，用作药物。
-
7.发明授权Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof 有权喹唑啉二酮衍生物，其制备及其各种治疗用途公开(公告)号：US08722659B2
公开(公告)日：2014-05-13
申请号：US13268164
申请日：2011-10-07
Applicant: Annie Clauss , Christophe Glaess , Gilbert Marciniak , Jean-Francois Nave , Bertrand Vivet
Inventor： Annie Clauss , Christophe Glaess , Gilbert Marciniak , Jean-Francois Nave , Bertrand Vivet
IPC: A01N43/00 , A61K31/33 , A01N43/54 , A61K31/517 , A01K31/00
CPC classification number: C07D407/04 , C07D239/96 , C07D309/14 , C07D335/02 , C07D405/04 , C07D405/14 , C07D409/04
Abstract: The subject matter of the invention is quinazolinedione derivatives of formula (I), methods for obtaining same and therapeutic uses thereof, such as cancer, diabetes, muscle diseases, bone diseases, cardiovascular diseases, central nervous system diseases, peripheral nervous system diseases, inter alia.
Abstract translation: 本发明的主题是式（I）的喹唑啉酮衍生物，其获得其治疗用途的方法，例如癌症，糖尿病，肌肉疾病，骨病，心血管疾病，中枢神经系统疾病，周围神经系统疾病， 特别是
-
8.发明申请QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND VARIOUS THERAPEUTIC USES THEREOF. 有权喹诺酮衍生物，其制备方法及其各种治疗方法。公开(公告)号：US20120115846A1
公开(公告)日：2012-05-10
申请号：US13268164
申请日：2011-10-07
Applicant: Annie CLAUSS , Christophe GLAESS , Gilbert MARCINIAK , Jean-Francois NAVE , Bertrand VIVET
Inventor： Annie CLAUSS , Christophe GLAESS , Gilbert MARCINIAK , Jean-Francois NAVE , Bertrand VIVET
IPC: A61K31/517 , C07D403/04 , A61P29/00 , A61P37/02 , A61P11/06 , A61P11/00 , A61P37/08 , A61P1/00 , A61P17/06 , A61P19/02 , A61P3/10 , A61P25/00 , A61P41/00 , A61P35/00 , A61P19/08 , A61P19/10 , A61P1/16 , A61P29/02 , A61P9/00 , A61P7/00 , A61P21/00 , A61P9/12 , A61P9/10 , A61P31/12 , A61P31/04 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/06 , A61P25/08 , A61P25/28 , A61P25/16 , C07D409/04 , C07D403/14
CPC classification number: C07D407/04 , C07D239/96 , C07D309/14 , C07D335/02 , C07D405/04 , C07D405/14 , C07D409/04
Abstract: The subject matter of the invention is quinazolinedione derivatives of formula (I), methods for obtaining same and therapeutic uses thereof, such as cancer, diabetes, muscle diseases, bone diseases, cardiovascular diseases, central nervous system diseases, peripheral nervous system diseases, inter alia.
Abstract translation: 本发明的主题是式（I）的喹唑啉酮衍生物，其获得其治疗用途的方法，例如癌症，糖尿病，肌肉疾病，骨病，心血管疾病，中枢神经系统疾病，周围神经系统疾病， 特别是
-
-
-
-
-
-
-
Search Results
8
records
(took 0.019 seconds)
